490
Views
14
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy

, , , &
Pages 299-307 | Received 28 Nov 2017, Accepted 12 Feb 2018, Published online: 29 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Douglas Darden, Marin Nishimura, Justin Sharim & Alan Maisel. (2019) An update on the use and discovery of prognostic biomarkers in acute decompensated heart failure. Expert Review of Molecular Diagnostics 19:11, pages 1019-1029.
Read now
Nicola Riccardo Pugliese, Iacopo Fabiani, Viola Zywicki, Matteo Mazzola, Andreina D’Agostino, Gian Giacomo Galeotti & Frank Lloyd Dini. (2019) Effects of sacubitril/valsartan on B-type natriuretic peptide circulating levels and loop diuretic dose in a case series of stabilized heart failure patients with left ventricular ejection fraction ≤35%. Current Medical Research and Opinion 35:sup3, pages 13-18.
Read now

Articles from other publishers (12)

Michelle Mason Parker & Mark Wigger. 2023. Managing Heart Failure in Primary Care: A Case Study Approach. Managing Heart Failure in Primary Care: A Case Study Approach 157 175 .
Lori B Daniels, Nicholas L Mills & Christian Mueller. (2022) Use of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in the emergency department. European Heart Journal. Acute Cardiovascular Care 11:5, pages 440-441.
Crossref
Yu Wang, Jiaping Xu, Jiehong Yang, Ling Zhang, Yuanjiang Pan, Liping Dou, Peng Zhou, Yizhou Xu, Chang Li, Yu He, Huifen Zhou, Li Yu, Jingwen Chen, Shuwei Huang, Wei Fu & Haitong Wan. (2021) Effects of Guanxinshutong Capsules as Complementary Treatment in Patients With Chronic Heart Failure: Study Protocol for a Randomized Controlled Trial. Frontiers in Pharmacology 11.
Crossref
Cornelia Mrazek, Ana-Maria Simundic, Maria Salinas, Alexander von Meyer, Michael Cornes, Josep Miquel Bauçà, Mads Nybo, Giuseppe Lippi, Elisabeth Haschke-Becher, Martin H. Keppel, Hannes Oberkofler, Thomas K. Felder & Janne Cadamuro. (2020) Inappropriate use of laboratory tests: How availability triggers demand – Examples across Europe. Clinica Chimica Acta 505, pages 100-107.
Crossref
Nestor Vasquez, Spencer Carter & Justin L. Grodin. (2020) Angiotensin Receptor–Neprilysin Inhibitors and the Natriuretic Peptide Axis. Current Heart Failure Reports 17:3, pages 67-76.
Crossref
Eftychios Siniorakis, Spyridon Arvanitakis, Maximilianos Elkouris, Efstratios Katsianos, Panayotis Pelonis & Antonia Tertipi. (2020) When sacubitril/valsartan met neprilysin and B-type natriuretic peptide in the labyrinth of biochemistry. Revista Portuguesa de Cardiologia (English Edition) 39:3, pages 177-178.
Crossref
Eftychios Siniorakis, Spyridon Arvanitakis, Maximilianos Elkouris, Efstratios Katsianos, Panayotis Pelonis & Antonia Tertipi. (2020) When sacubitril/valsartan met neprilysin and B-type natriuretic peptide in the labyrinth of biochemistry. Revista Portuguesa de Cardiologia 39:3, pages 177-178.
Crossref
Borja Quiroga, Antonio de Santos, David Sapiencia, Yamila Saharaui & Vicente Álvarez-chiva. (2019) Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view. Nefrología (English Edition) 39:6, pages 646-652.
Crossref
Borja Quiroga, Antonio de Santos, David Sapiencia, Yamila Saharaui & Vicente Álvarez-Chiva. (2019) Experiencia clínica con sacubitrilo/valsartán en pacientes con insuficiencia renal: la visión del nefrólogo. Nefrología 39:6, pages 646-652.
Crossref
Evgeniya E Feygina, Marina M Artemieva, Alexander B Postnikov, Natalia N Tamm, Marina N Bloshchitsyna, Natalia A Medvedeva, Alexey G Katrukha & Alexander G Semenov. (2019) Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure. Clinical Chemistry 65:10, pages 1239-1247.
Crossref
Janani Rangaswami, Vivek Bhalla, John E.A. Blair, Tara I. Chang, Salvatore Costa, Krista L. Lentine, Edgar V. Lerma, Kenechukwu Mezue, Mark Molitch, Wilfried Mullens, Claudio Ronco, W.H. Wilson Tang & Peter A. McCullough. (2019) Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 139:16.
Crossref
Janani Rangaswami & Roy O. Mathew. (2018) Pathophysiological Mechanisms in Cardiorenal Syndrome. Advances in Chronic Kidney Disease 25:5, pages 400-407.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.